Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/28786
Title: | High-Sensitive Cardiac Troponin Predicts 2-years Mortality in Patients with Coronary Artery Disease-subanalysis of the GLOBAL LEADERS trial | Authors: | Chang, Chun Chin Chichareon, Ply Kogame, Norihiro Modolo, Rodrigo Takahashi, Kuniaki Cequier, Angel Carrie, Didier Stables, Rod Royaards, Kees-Jan vom Dahl, Juergen Onuma, Yoshinobu Hamm, Christian VRANCKX, Pascal Valgimigli, Marco Windecker, Stephan Serruys, Patrick |
Issue Date: | 2018 | Publisher: | ELSEVIER SCIENCE INC | Source: | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(13), p. B314-B314 (Art N° TCT-787) | Notes: | [Chang, Chun Chin] Erasmus Univ, Thoraxctr, Med Ctr, Rotterdam, Netherlands. [Chichareon, Ply; Kogame, Norihiro; Modolo, Rodrigo; Takahashi, Kuniaki] Acad Med Ctr, Amsterdam, Netherlands. [Cequier, Angel] Bellvitge Univ Hosp, Barcelona, Spain. [Carrie, Didier] Rangueil Hosp Toulouse, Toulouse, France. [Stables, Rod] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England. [Royaards, Kees-Jan] Maasstad Hosp, Rotterdam, Netherlands. [vom Dahl, Juergen] Kliniken Maria Hilf, Monchengladbach, Germany. [Onuma, Yoshinobu] Erasmus MC, Thoraxctr, Rotterdam, Netherlands. [Hamm, Christian] Kerckhoff Clin, Bad Nauheim, Germany. [Vranckx, Pascal] Hartctr Hasselt, Hasselt, Belgium. [Valgimigli, Marco] Inselpsital, Swiss Cardiovasc Ctr, Bern, Switzerland. [Windecker, Stephan] Univ Hosp Bern, Bern, Switzerland. [Serruys, Patrick] Imperial Coll, London, England. | Document URI: | http://hdl.handle.net/1942/28786 | ISSN: | 0735-1097 | e-ISSN: | 1558-3597 | DOI: | 10.1016/j.jacc.2018.08.2019 | ISI #: | 000455137100775 | Rights: | 2018 Published by Elsevier Inc. | Category: | M | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
chang 1.pdf Restricted Access | Published version | 142.43 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.